BOTOTLSJU
MPLT

Board of Trustees of The Leland Stanford Junior University’s MapLight Therapeutics MPLT Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-199,231
Closed -$4.05M – 25
2026
Q1 		$4.05M Sell
199,231
-2
-0% -$36 0.48% 7
2025
Q4 		$3.5M Buy
+199,233
New +$3.34M 0.71% 7

Other funds holding MPLT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's MPLT Position: Q2 2026 in Review

Board of Trustees of The Leland Stanford Junior University sold out of MapLight Therapeutics (MPLT) in Q2 2026, closing a stake of 199,231 shares — an estimated $4.05M sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in MPLT in Q4 2025 and held it in 2 quarters. The position peaked at $4.05M in Q1 2026. 41 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

  • Board of Trustees of The Leland Stanford Junior University reported no remaining MapLight Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Board of Trustees of The Leland Stanford Junior University sold 199,231 MapLight Therapeutics shares in Q2 2026, an estimated $4.05M.
  • Board of Trustees of The Leland Stanford Junior University first reported a position in MapLight Therapeutics in Q4 2025 and held it in 2 quarters.
  • Board of Trustees of The Leland Stanford Junior University's MapLight Therapeutics position peaked at $4.05M in Q1 2026.
  • 41 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q2 2026, filed 12 Aug 2026.